Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29270064 | 0.90 | TAAR1 (0.47) | ESR1ESR2TAAR1CYP3A4 | |
| SCHEMBL8600868 | 0.89 | NPC1 (0.46) | CYP3A4SMN1; SMN2 | |
| SCHEMBL3602247 | 0.86 | — | — | |
| SCHEMBL9066235 | 0.84 | ESR1 (0.33) | GABRA1GABRB2ESR1ESR2TAAR1 | |
| SCHEMBL8599213 | 0.80 | MAPK1 (0.31) | CYP3A4SMN1; SMN2 | |
| SCHEMBL6373766 | 0.73 | MIF (0.32) | — | |
| SCHEMBL11855202 | 0.72 | CYP3A4 (0.46) | GABRA1GABRB2CYP3A4 | |
| SCHEMBL5737958 | 0.72 | NR3C1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL9404584 | 0.72 | CA2 (0.45) | GABRA1GABRB2 | |
| SCHEMBL11119059 | 0.72 | CYP2C19 (0.38) | ESR1ESR2TAAR1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115135803-B | Electroless plating base agent containing polymer and metal microparticles | 日产化学株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-1190502-C | Hydrophobic-imparting polysiloxanes | BAYER AG (DE) | 2005-02-23 | — | — | CN | disclosed |